Search
for
Sort by
Research 241–270 of 1000+
- ‘The psychosocial burden of alopecia areata and androgenetica’: a cross‐sectional multicentre study among dermatological out‐patients in 13 European countries
- Epidemiology of alopecia areata in Baqubah city/Diyala-Iraq
- The Effects of Environmental Pollutants and Exposures on Hair Follicle Pathophysiology
- Alopecia areta: a review
- Gut microbiota in alopecia areata
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Minoxidil for patchy alopecia areata: systematic review and meta‐analysis
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- Stressful lie events in alopecia areata patients: A case control study
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study
- Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- TREATMENT OF ALOPECIA AREATA WITH ORAL METHYLPREDNISOLONE COMBINED WITH FRACTIONAL MICRONEEDLE RADIOFREQUENCY
- Ritlecitinib in severe alopecia areata: a profile of its use
- Parenting Styles and Psychological Effects on Children with Alopecia Areata: Exploring Family Dynamics, Anxiety, and Depression
- Gut Microbiota and Its Association with Alopecia Areata: Insights from a Two-Sample Mendelian Randomization Study
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Development of Uniform Protocol for Alopecia Areata Clinical Trials
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Treatment Outcomes of Triamcinolone Acetonide Compared with Cryotherapy in Alopecia Areata: Evidence from a Systematic Review and Meta-Analysis
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Factors Associated with Severity of Alopecia Areata
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Diagnostic challenges in determining alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients